Page last updated: 2024-12-11
linolenyl alcohol
Description
linolenyl alcohol: RN given refers to (Z,Z,Z)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
(9Z,12Z,15Z)-octadecatrien-1-ol : A long chain fatty primary alcohol that is octadecanol containing three double bonds located at positions 9, 12 and 15. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
ID Source | ID |
PubMed CID | 6436081 |
CHEBI ID | 77474 |
SCHEMBL ID | 59807 |
MeSH ID | M0114469 |
Synonyms (23)
Synonym |
506-44-5 |
(9z,12z,15z)-9,12,15-octadecatrien-1-ol |
linolenyl alcohol |
(9z,12z,15z)-octadeca-9,12,15-trien-1-ol |
einecs 208-039-7 |
yc8dmo65r7 , |
unii-yc8dmo65r7 |
9,12,15-octadecatrien-1-ol, (9z,12z,15z)- |
SCHEMBL59807 |
linolenic alcohol |
(z,z,z)-9,12,15-octadecatrien-1-ol |
all-cis-9,12,15-octadecatrien-1-ol |
cis,cis,cis-9,12,15-octadecatrien-1-ol |
9,12,15-octadecatrien-1-ol, (z,z,z)- |
linolenyl alcohol [usp-rs] |
cis,cis,cis-9,12,15-octadecatrienol |
(9z,12z,15z)-octadecatrienyl alcohol |
(9z,12z,15z)-1-octadecatrienol |
(9z,12z,15z)-octadecatrien-1-ol |
CHEBI:77474 |
(9e,12e,15e)-9,12,15-octadecatrien-1-ol # |
Q27147009 |
DTXSID80880766 |
Research Excerpts
Effects
Roles (1)
Role | Description |
antibacterial agent | A substance (or active part thereof) that kills or slows the growth of bacteria. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Drug Classes (1)
Class | Description |
long-chain primary fatty alcohol | A long-chain fatty alcohol in which the hydroxy group is attached to a methylene (CH2) group. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 23.12
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 23.12 (24.57) | Research Supply Index | 1.79 (2.92) | Research Growth Index | 4.32 (4.65) | Search Engine Demand Index | 21.17 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |